Matt Posard

Insider profile

Performance

Overall performance
3.0

Performance over holding periods
3.0
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 42% 68% 82%
Transactions
12 33% Buy
34 71% Buy
47 69% Buy
Matt Posard's trades of Halozyme Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-08-14 2024-08-14 S Sale
3,302 -9.4%
10.91
US$3,977,611
3,302 -9.4% 10.91 US$3,977,611
2024-08-14 2024-08-13 S Sale
28,070 -13.2%
238.10
US$3,917,334
28,070 -13.2% 238.10 US$3,917,334
2024-08-07 2024-08-13 PrS Proposed sale
87,494
499.35
US$1,771,975
87,494 499.35 US$1,771,975
2024-08-14 2024-08-12 S Sale
10,000 -10.0%
55.72
US$557,230
10,000 -10.0% 55.72 US$557,230
2024-06-13 2024-06-12 S Sale
10,000 -9.1%
50.62
US$506,190
10,000 -9.1% 50.62 US$506,190
2024-06-13 2024-06-11 S Sale
10,000 -8.4%
50.01
US$500,110
10,000 -8.4% 50.01 US$500,110
2024-06-11 2024-06-11 PrS Proposed sale
20,000
50.00
US$1,000,000
20,000 50.00 US$1,000,000
2022-12-06 2022-12-06 S Sale
10,000 -8.7%
56.12
US$561,180
10,000 -8.7% 56.12 US$561,180
2022-12-06 2022-12-05 S Sale
10,000 -8.0%
55.74
US$557,370
10,000 -8.0% 55.74 US$557,370
2022-12-06 2022-12-02 S Sale
10,000 -7.4%
58.80
US$588,000
10,000 -7.4% 58.80 US$588,000
2021-12-01 2021-12-01 B Purchase
10,000 +25.0%
4.45
US$44,493
10,000 +25.0% 4.45 US$44,493
2021-12-01 2021-12-01 B Purchase
10,000 +33.3%
4.46
US$44,612
10,000 +33.3% 4.46 US$44,612
2021-12-01 2021-12-01 B Purchase
10,000 +50.0%
4.50
US$45,000
10,000 +50.0% 4.50 US$45,000
2021-12-01 2021-11-30 B Purchase
20,000 +inf%
4.57
US$91,400
20,000 +inf% 4.57 US$91,400
2021-02-19 2021-02-17 B Purchase
62,500 +inf%
16.00
US$1,000,000
62,500 +inf% 16.00 US$1,000,000
2021-01-13 2021-01-11 B Purchase
33,898 +64.0%
29.50
US$999,991
33,898 +64.0% 29.50 US$999,991